Literature DB >> 2688544

Antibiotic therapy for bronchopulmonary infections in cystic fibrosis. The American approach.

M I Marks1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2688544     DOI： 10.1159/000417624

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN： 0066-4758


× No keyword cloud information.
  4 in total

Review 1.  Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.

Authors:  N Høiby; C Koch
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

2.  Time-survival studies for quantifying effects of azlocillin and tobramycin on Pseudomonas aeruginosa.

Authors:  M M McFarland; E M Scott; A Li Wan Po
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 3.  Therapeutic approaches to cystic fibrosis: memorandum from a joint WHO/ICF(M)A meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

4.  Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review.

Authors:  Donald R Vandevanter; David E Geller
Journal:  Med Devices (Auckl)       Date:  2011-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.